Back to top

Image: Bigstock

New Strong Buy Stocks for December 28th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Akebia Therapeutics, Inc. (AKBA - Free Report) : This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 30 days.

AKEBIA THERAP Price and Consensus

 

Blueprint Medicines Corporation (BPMC - Free Report) : This developer of drugs of small molecule kinase inhibitors has seen the Zacks Consensus Estimate for its current year earnings surging 5.2% over the last 30 days.

BLUEPRINT MED Price and Consensus

 

Cytokinetics, Incorporated (CYTK - Free Report) : This late stage biopharmaceutical company focusing on the discovery and development of novel small molecule therapeutics has witnessed the Zacks Consensus Estimate for its current year earnings soaring 75.5% over the last 30 days.

CYTOKINETCS INC Price and Consensus

 

Farmers Capital Bank Corporation : This provider of banking and bank-related services has seen the Zacks Consensus Estimate for its current year earnings advancing 0.4% over the last 30 days.

FARMERS CAP KY Price and Consensus

 

First Financial Corporation (THFF - Free Report) : This provider of various financial services including commercial, mortgage, and consumer lending has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 30 days.

FIRST FINL-IND Price and Consensus

 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Now See All Our Private Trades

While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum  . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>

Published in